Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus

The features of hepatitis C virus patients with a sustained virologic response (SVR) who developed hepatocellular carcinoma (HCC) after direct-acting antiviral (DAA) therapy are unclear. The study population included 1494 DAA-SVR patients without a history of HCC. The cumulative carcinogenesis rate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2022-01, Vol.17 (1), p.e0262267-e0262267
Hauptverfasser:	Mawatari, Seiichi, Kumagai, Kotaro, Oda, Kohei, Tabu, Kazuaki, Ijuin, Sho, Fujisaki, Kunio, Tashima, Shuzo, Inada, Yukiko, Uto, Hirofumi, Saisyoji, Akiko, Hiramine, Yasunari, Hashiguchi, Masafumi, Tamai, Tsutomu, Hori, Takeshi, Taniyama, Ohki, Toyodome, Ai, Sakae, Haruka, Kure, Takeshi, Sakurai, Kazuhiro, Moriuchi, Akihiro, Kanmura, Shuji, Ido, Akio
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Albumins Antiviral agents Antiviral Agents - adverse effects Antiviral drugs Biology and life sciences Carcinogenesis Carcinogens Carcinoma, Hepatocellular - chemically induced Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - virology Care and treatment Complications and side effects Environmental science Female Follow-Up Studies Gastroenterology Hepacivirus - drug effects Hepatitis Hepatitis C Hepatitis C virus Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Hepatocellular carcinoma Hepatology Hepatoma Hospitals Humans Hyaluronic acid Infections Internal medicine Lifestyles Liver cancer Liver diseases Liver Neoplasms - chemically induced Liver Neoplasms - pathology Liver Neoplasms - virology Magnetic resonance imaging Male Medicine and Health Sciences Patient outcomes Patients Population Population studies Prognosis Prospective Studies Risk Factors Sex Survival Rate University graduates Viruses α-Fetoprotein
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!